Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2026-02-11 @ 12:39 AM
Study NCT ID:
NCT02616250
Status:
COMPLETED
Last Update Posted:
2021-02-18
First Post:
2015-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Sponsor:
Galderma R&D
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RD.03.SPR.105069
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None